期刊文献+

MR心肌首过灌注成像评估肥厚型心肌病心肌缺血 被引量:13

MR first-pass myocardial perfusion imaging in evaluation of myocardial ischemia in hypertrophic cardiomyopathy
下载PDF
导出
摘要 目的采用MR心肌首过灌注成像评估肥厚型心肌病(HCM)心肌缺血情况。方法选取20例HCM患者(HCM组)和10名健康志愿者(对照组)行CMR检查(包括左心室短轴电影、心肌首过灌注成像和延迟增强扫描),测量舒张末期心肌厚度(EDTH),绘制左心室基底部、中部及心尖部的血池-信号强度心肌灌注曲线,获得各节段达峰时间(t_(peak))、心肌信号强度最大上升斜率(Slope_(max))、峰值信号强度(SI_(peak))等。根据EDTH,将HCM组各心肌节段分为非肥厚亚组和肥厚亚组,肥厚亚组又分为轻度肥厚(15~19mm)、中度肥厚(20~24mm)和重度肥厚(25~29mm)节段3个水平,采用单因素方差分析比较所有组别t_(peak)、Slope_(max)、SI_(peak)的总体差异,对HCM各亚组及各水平的t_(peak)、Slope_(max)、SI_(peak)行两两检验。结果对照组与HCM非肥厚亚组的Slope_(max)、t_(peak)差异均无统计学意义(P均>0.05)。HCM非肥厚亚组与HCM肥厚亚组Slope_(max)、t_(peak)差异均有统计学意义(P均<0.05)。HCM肥厚亚组中,轻度肥厚水平Slope_(max)明显高于中度和重度肥厚(P均<0.05),中度肥厚水平t_(peak)高于轻度肥厚(P<0.05);中度与重度肥厚间Slope_(max)、t_(peak)及轻度、中度和重度肥厚间SI_(peak)差异均无统计学意义(P均>0.05)。结论 MR心肌首过灌注成像可反映HCM不同肥厚节段的心肌缺血情况,有助于对HCM患者进行风险分层、制定治疗计划和预后评估。 Objective To evaluate the myocardial ischemia in hypertrophic cardiomyopathy (HCM) patients with MR first-pass myocardial perfusion imaging. Methods Totally 20 patients with HCM (HCM group) and 10 healthy volunteers (control group) underwent cardiac MR scanning, including left ventricle short axial cine, first-pass myocardial perfusion imaging and delayed enhanced imaging. Then the left ventricular end-diastolic wall thickness (EDTH) was measured. The blood pool-signal strength curves of the near, middle and far segments of left ventricle were drawn, and then time to peak (tpoak), maximal upslope of time-intensity curve (S1opemax), peak signal intensity (SIpeak) were measured. According to EDTH, different segments of HCM were divided into non-hypertrophic subgroup and hypertrophic subgroup, and patients in hypertrophic subgroup were further divided as slightly (15-19 ram), moderately (20-24 ram) and severely hypertrophic level (25-29 mm). One-way ANOVA analysis was used to analyze the differences of tpeak, Slope SIpeak among groups, as well as every two subgroups and levels. Results The differences of Slopemax, tpeak between control group and non-hypertrophic group were riot statistically significant ( both P 〉0. 05 ). The differences of Slope^x and tp^k between non- hypertrophic group and hypertrophic group were statistically significant (both P〈0.05). In hypertrophic subgroup, Slopemax of slightly hypertrophic level was higher than that of moderately and severely hypertrophic level (both P〈 0.05), and tpeak of moderately hypertrophic level was higher than that of slightly hypertrophic level (P〈0. 05). However, Slopemax and tpeak between moderately and severely hypertrophic level, SIpeak between every two levels were not significantly different (all P〉0.05). Conclusion MR first-pass myocardial perfusion imaging can reflect myocardial ischemia of different hypertrophic segments of HCM, contributing to risk stratification, therapy planning and prognosis evaluation of HCM patients.
出处 《中国医学影像技术》 CSCD 北大核心 2018年第2期214-218,共5页 Chinese Journal of Medical Imaging Technology
关键词 心肌病 肥厚型 冠状血管 心肌缺血 灌注成像 磁共振成像 Cardiomyopathy, hypertrophic Coronary vessels Myocardial ischemia Perfusion imaging Magneticresonance imaging
  • 相关文献

参考文献3

二级参考文献12

  • 1赵世华,闫朝武,杨敏福,陆敏杰,蒋世良,李世国,张岩,刘琼,刘玉清,何作祥.磁共振心肌灌注延迟增强与核素心肌灌注/代谢显像识别存活心肌对比研究[J].中华心血管病杂志,2006,34(12):1072-1076. 被引量:26
  • 2Eugene B 陈灏珠(译).心脏病学(第5版)[M].北京:人民卫生出版社,2001.1086-1094.
  • 3Petersen SE, Jerosch-Herold M, Hudsmith LE, et aL Evidence for microvascular dysfunction in hypertrophic eardiomyopathy: New insights from multiparametri magnetic resonance imaging. Circulation, 2007,115(18) : 2418-2425.
  • 4To AC, Dhilion A, Desai MY. Cardiac magnetic resonance in hy- pertrophic cardiomyopathy. JACC Cardiovasc Imaging, 2011, 4 (10) : 1123-1137.
  • 5Knaapen P, Germans T, Camici PG, et al. Determinants of coro- nary microvascular dysfunction in symptomatic hypertrophic car- diomyopathy. Am J Physiol Heart Cite Physiol, 2008, 294 (2): H986-H993.
  • 6Cecchi F, Sgalambro A, Baldi M, et al. Microvascular dysfunc- tion, myocardial ischemia, and progression to heart failure in pa- tients with hypertrophic cardiomyopathy. J Cardiovasc Transl Res, 2009,2(4) :452-461.
  • 7Maron BJ. Contemporary insights and strategies for risk stratifi- cation and prevention of sudden death in hypertrophic cardiomyop- athy. Circulation, 2010,121(3) :445-456.
  • 8O'hanlon R, Grasso A, Roughton M, et al. Prognostic signifi- cance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coil Cardiol, 2010,56(11) :867-874.
  • 9Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dys- function and prognosis in hypertrophic cardiomyopathy. N Engl J Med, 2003,349(11) :1027-1035.
  • 10杨娅,李治安,王新房,刘俐,谢明星,吕清.冠脉血流显像技术无创性评价肥厚型心肌病的冠脉血流及冠脉血流储备[J].中国医学影像技术,2000,16(1):10-12. 被引量:11

共引文献44

同被引文献69

引证文献13

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部